Pediatrix Medical (MD)

What Moves the Stock

1. 01Medicaid reimbursement rate changes at state level - affects 50% of patient mix and directly impacts margins
2. 02Commercial payer mix shift - commercial rates typically 2-3x Medicaid rates, so patient mix materially affects revenue per encounter
3. 03Same-unit volume growth in existing NICU contracts - driven by birth rates and NICU admission rates (acuity)
4. 04Physician recruitment and retention costs - competitive labor market for neonatologists affects compensation expense
5. 05New hospital contract wins or losses - exclusivity agreements are multi-year but subject to competitive rebids
6. 06Neonatal intensive care physician services (estimated 55-60% of revenue) - 24/7 NICU coverage contracts with hospitals
7. 07Maternal-fetal medicine services (estimated 25-30% of revenue) - high-risk pregnancy management and ultrasound diagnostics
8. 08Pediatric subspecialty services (estimated 10-15% of revenue) - pediatric cardiology, anesthesiology, and hospitalist programs

MD Chart

My Notes

• value - Trading at 1.0x sales and 8.4x EV/EBITDA with 9.9% FCF yield despite negative operating margins suggests deep value investors…
• Rising interest rates increase borrowing costs on the company's debt (0.72 debt/equity ratio)…
• Watch on earnings: US birth rate trends (CDC monthly data) - leading indicator of addressable market size, State Medicaid reimbursement rate changes - particularly in high-exposure states like Florida, Texas, California, Neonatologist supply and compensation trends (AAP workforce data) - affects physician recruitment costs.